LEADER 01715oam  2200433   450 
001 9910716948903321
005 20211112160357.0
024 8 $a44-853
035   $a(CKB)5470000002526707
035   $a(OCoLC)1285135718
035   $a(EXLCZ)995470000002526707
100   $a20211112d2021      ua             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 14$aThe SACKLER Act and other policies to promote accountability for the Sackler family's role in the opioid epidemic $ehearing before the Committee on Oversight and Reform, House of Representatives, One Hundred Seventeenth Congress, first session, June 8, 2021
210  1$aWashington :$cU.S. Government Publishing Office,$d2021.
215   $a1 online resource (iii, 61 pages)
300   $aAccess ID (govinfo): CHRG-117hhrg44853.
300   $a"Serial no. 117-27."
517   $aSACKLER Act and other policies to promote accountability for the Sackler family's role in the opioid epidemic 
606   $aOpioid abuse$zUnited States
606   $aDrugs$zUnited States$xMarketing
606   $aPharmaceutical industry$xCorrupt practices$zUnited States
606   $aDrug addiction$zUnited States
608   $aLegislative hearings.$2lcgft
615  0$aOpioid abuse
615  0$aDrugs$xMarketing.
615  0$aPharmaceutical industry$xCorrupt practices
615  0$aDrug addiction
801  0$bGPO
801  1$bGPO
801  2$bGPO
906   $aBOOK
912   $a9910716948903321
996   $aThe SACKLER Act and other policies to promote accountability for the Sackler family's role in the opioid epidemic$93452529
997   $aUNINA